FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Zeta Given Another Hat at FDA Special Counsel

FDA deputy commissioner for strategic initiatives Lowell M. Zeta adds Special Counsel for FDA role to his duties.

latest-news-card-1
Human Drugs

Bipartisan Push Seeks Boost in ALS Research

Congressman Jason Crow (D-CO) leads a bipartisan group of lawmakers in a push to significantly expand federal funding for Amyotrophic Lateral Sclerosi...

latest-news-card-1
Human Drugs

Enhertu Combo Delays Breast Cancer Progression

A new combination therapy involving AstraZeneca and Daiichi Sankyos Enhertu (trastuzumab deruxtecan) and pertuzumab (Genentechs Perjeta) shows signifi...

latest-news-card-1
FDA General

FDA Budget Proposal Details $400 Million in Cuts

FDA releases its FY 2026 budget proposal showing that the agencys overall budget would decrease by 4% ($271 million) to $6.8 billion beginning 10/1.

Biologics

Moderna Wins OK for Next-Gen Covid Vaccine

FDA approves Modernas next-generation Covid-19 vaccine, Nexspike (mRNA-1283), for use in all adults 65 and older, and individuals aged 12-64 years wit...

latest-news-card-1
Human Drugs

Appeals Court Halts Federal Layoffs

A federal appeals court upholds a freeze on layoffs across FDA and other major federal agencies, rejecting an effort by the Trump administration to li...

Medical Devices

Improved Swoop Portable Brain MRI Cleared

FDA clears a Hyperfine 510(k) for its next-generation AI-powered portable MRI system for the brain, the Swoop system.

latest-news-card-1
FDA General

FDA Launches Elsa AI Tool for Efficiencies

FDA launches a generative Artificial Intelligence tool called Elsa that is designed to help employees from scientific reviewers to investigators wor...

latest-news-card-1
Human Drugs

MAHA Report Questioned on Nonexistent Science

Critics call out HHS secretary Robert F. Kennedy Jr.s recent Make America Healthy Again report for citing allegedly nonexistent scientific studies.

latest-news-card-1
Human Drugs

Guide on Bioequivalence for Immediate-Release Drugs

FDA releases a draft guidance entitled M13B Bioequivalence for Immediate-Release Solid Oral Dosage Forms: Additional Strengths Biowaiver.